Environment
Early Warning Signs: UVM Scientists Offer New Clues in Fight Against Disease Devastating Sea Star Populations
New Leading Cause of Tree Death in U.S. Northeast Shifts From Logging to Natural Causes
One-of-a-kind experiment tracked plant evolution in response to climate change at 30 sites worldwide
Twenty feet of peat: Who lies beneath UVM’s newest Natural Area?
Could Rising Oil Prices and Political Uncertainty from War with Iran Fuel a New Era of Green Energy? UVM Experts Weigh in.
UVM Study Finds Wildfire Smoke Worsened Pediatric Asthma in the Northeast
In the first study of wildfire smoke’s effects on children with asthma in the Northeast, UVM researchers reveal growing health risks for the region as climate change fuels more smoke-filled summers.
UVM Study Finds Wildfire Smoke Worsened Pediatric Asthma in the Northeast
In the first study of wildfire smoke’s effects on children with asthma in the Northeast, UVM researchers reveal growing health risks for the region as climate change fuels more smoke-filled summers.
Stay Informed. Stay Inspired.
Sign up for the latest news on UVM discoveries with the Research Matters newsletter.
Health and Medicine
UVM Faculty and Students Team Up on Toddler Research
UVM Undergraduates Co Author Peer-Reviewed Study on Western Diet, Binge Drinking, and Liver Disease
Larner Faculty to Lead Largest U.S. Medical Specialty Organization
New Tool Can Better Diagnose Parkinson’s Disease
For 15 Years, Bridges to Health has Found and Filled the Gaps in Care for Vermont's Agricultural Industry
A UVM-Tested Dengue Vaccine Gains First Major Approval
The world’s first single-dose vaccine to prevent dengue fever has been approved for licensure in one of the largest countries affected by the disease, following 16 years of research by scientists at the UVM, in partnership with the NIH and the Johns Hopkins Bloomberg School of Public Health.
Read the storyA UVM-Tested Dengue Vaccine Gains First Major Approval
The world’s first single-dose vaccine to prevent dengue fever has been approved for licensure in one of the largest countries affected by the disease, following 16 years of research by scientists at the UVM, in partnership with the NIH and the Johns Hopkins Bloomberg School of Public Health.
Read the storyScience and Technology
Investigating What Lies Below
Real Data. Real Benefits.
See the positive outcomes for Vermont and the nation that flow from UVM research.
Culture and Society
Naturally Fearless? A UVM Neuroscientist on How Elite Athletes View Risk
